Company NewsInstem Announces Major UK Headquarters RefurbishmentInstem TeamMarch 3, 2026Modernised Headquarters Underscores Instem’s Commitment to Innovation, Customer Excellence and the Local Region
ClinicalCompany NewsPress ReleasesInstem Relaunches the d-wise Brand to Support the Clinical Research CommunityInstem TeamJanuary 28, 2026We are excited to announce the revival of the d-wise brand to represent Instem’s Clinical Trial Analytics and Transparency offerings. This movement returns our clinical portfolio to its roots while reinforcing our dedication to supporting...
Company NewsPress ReleasesInstem Unveils New Global Headquarters in Boston, MAInstem TeamDecember 2, 2025A Bold Step Reflecting Customer Obsession, Strategic Growth, and a New Era for Instem
Company NewsPress ReleasesUnifying Acquisitions Under One Instem BrandMike Thurogood, CMktrNovember 4, 2025A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
Company NewsPress ReleasesInstem achieves a major milestone, acquires all shares of Xybion from Banerjee Group LLC controlled by Dr. Pradip K. BanerjeeInstem TeamJuly 31, 2025Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Company NewsPress ReleasesInstem Announces Acquisition of RockStep Solutions, Inc.Instem TeamJuly 28, 2025Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration